The company obtained the invention patent ‘’a preparation method of solid-phase peptide synthesis anti-inflammatory decapeptide”

The company has recently obtained an invention patent certificate issued by the State Intellectual Property Office. The details are as follows:
Title of invention: A solid-phase peptide synthesis method for preparing anti-inflammatory decapeptides
Patent number: ZL 2014 1 0332269.X
Patent application date: 2014 July 14
Patentee: Shanghai Soho-Yiming Pharmaceutical Co., Ltd.
Authorization Announcement Date: October 19, 2016
Certificate Number: 2279430
The term of the patent right for this patent is twenty years, counting from the date of application.
Anti-inflammatory decapeptide is a synthetic peptide drug composed of ten amino acids, used to treat ulcerative colitis (IBD). With the continuous improvement of people's living standards, ulcerative colitis (IBD) is the main disease of inflammatory bowel disease and has become a common disease that endangers human health. At present, there are no specific chemotherapy drugs for treating this disease. Once this product is on the market, it is expected to overcome IBD that is harmful to human health.
The new patents are being used in the company's new product research and development, which is conducive to improving the company's intellectual property protection system, further exerting the company's independent intellectual property advantages, and enhancing the company's core competitiveness.